This is an £800m company. Feels to me like it should be getting beyond 2Bn now. Im no expert but its financials look great in terms of revenue and R+D and just compare their website with other biotechs, and the amount of good press recently on the news and panorama.
Perhaps iv got a lot to learn but iv put 1200 in this thing and id like to push it up towards 4000 by June.
Maybe thats biotech compared with other types of stock, biotechs spike on concrete news?